Laurent Fischer, CEO and Director at Adverum Biotechnologies, Inc. (ADVM), bought 20,000 shares at $9.88 ($198K) on 2021-03-24, disclosed to the SEC on 2021-03-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.88 | 10,000 | $99K | 50.0% |
| 2 | $9.88 | 10,000 | $99K | 50.0% |
| Total | $9.88 avg | 20,000 | $198K | 100% |
| Filing → |
| ADVM | SELL | 2023-03-17 | $32K | — | Filing → |
| ADVM | SELL | 2022-09-21 | $44K | — | Filing → |
| ADVM | BUY | 2022-04-22 | $28K | — | Filing → |